These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33048886)

  • 41. Regarding "Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors".
    Biscione FM
    J Acquir Immune Defic Syndr; 2007 Dec; 46(4):510; author reply 510-2. PubMed ID: 17993860
    [No Abstract]   [Full Text] [Related]  

  • 42. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.
    Rubin LH; Sundermann EE; Moore DJ
    J Neurovirol; 2019 Oct; 25(5):661-672. PubMed ID: 30671777
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of HIV Subtype and Antiretroviral Therapy on HIV-Associated Neurocognitive Disorder Stage in Rakai, Uganda.
    Sacktor N; Saylor D; Nakigozi G; Nakasujja N; Robertson K; Grabowski MK; Kisakye A; Batte J; Mayanja R; Anok A; Gray RH; Wawer MJ
    J Acquir Immune Defic Syndr; 2019 Jun; 81(2):216-223. PubMed ID: 30865184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Routine detection and management of neurocognitive impairment in HIV-positive patients in a UK centre.
    Haddow LJ; Accoroni A; Cartledge JD; Manji H; Benn P; Gilson RJ
    Int J STD AIDS; 2013 Mar; 24(3):217-9. PubMed ID: 23535355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders.
    Fattakhov N; Torices S; Stangis M; Park M; Toborek M
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders.
    Levine AJ; Martin E; Sacktor N; Munro C; Becker J;
    J Acquir Immune Defic Syndr; 2017 Jun; 75(2):203-210. PubMed ID: 28328547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
    Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
    Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable.
    M Elicer I; Byrd D; Clark US; Morgello S; Robinson-Papp J
    J Neurovirol; 2018 Aug; 24(4):514-522. PubMed ID: 29696578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuropsychological deficit in haemophiliacs with human immunodeficiency virus.
    Turnbull O; Saling MM; Kaplan-Solms K; Cohn R; Schoub B
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):175-7. PubMed ID: 2019847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy.
    Deutsch R; Ellis RJ; McCutchan JA; Marcotte TD; Letendre S; Grant I;
    AIDS; 2001 Sep; 15(14):1898-9. PubMed ID: 11579260
    [No Abstract]   [Full Text] [Related]  

  • 51. Validity of the International HIV Dementia Scale in South Africa.
    Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
    AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurological soft signs (NSS) and cognitive deficits in HIV associated neurocognitive disorder.
    Forno G; Henríquez F; Ceballos ME; Gonzalez M; Schröder J; Toro P
    Neuropsychologia; 2020 Sep; 146():107545. PubMed ID: 32593722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection.
    Weber E; Morgan EE; Iudicello JE; Blackstone K; Grant I; Ellis RJ; Letendre SL; Little S; Morris S; Smith DM; Moore DJ; Woods SP;
    J Neurovirol; 2013 Feb; 19(1):65-74. PubMed ID: 23250704
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low levels of neurocognitive impairment detected in screening HIV-infected men who have sex with men: The MSM Neurocog Study.
    Barber TJ; Bansi L; Pozniak A; Asboe D; Nelson M; Moyle G; Davies N; Margetts A; Ratcliffe D; Catalan J; Boffito M; Gazzard B
    Int J STD AIDS; 2017 Jun; 28(7):715-722. PubMed ID: 27510645
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Problems screening for HAND among the educationally disadvantaged.
    Musso MW; Cosgrove SJ; Peltier MR; McGee BL; Jones GN
    Appl Neuropsychol Adult; 2018; 25(2):120-125. PubMed ID: 27841663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature.
    Zipursky AR; Gogolishvili D; Rueda S; Brunetta J; Carvalhal A; McCombe JA; Gill MJ; Rachlis A; Rosenes R; Arbess G; Marcotte T; Rourke SB
    AIDS; 2013 Sep; 27(15):2385-401. PubMed ID: 23751261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Alzheimer's disease-8 and Montreal Cognitive Assessment as screening tools for neurocognitive impairment in HIV-infected persons.
    Overton ET; Azad TD; Parker N; Demarco Shaw D; Frain J; Spitz T; Westerhaus E; Paul R; Clifford DB; Ances BM
    J Neurovirol; 2013 Feb; 19(1):109-16. PubMed ID: 23345074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal brain atrophy patterns and neuropsychological performance in older adults with HIV-associated neurocognitive disorder compared with early Alzheimer's disease.
    Milanini B; Samboju V; Cobigo Y; Paul R; Javandel S; Hellmuth J; Allen I; Miller B; Valcour V
    Neurobiol Aging; 2019 Oct; 82():69-76. PubMed ID: 31425903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population.
    Almeida F; Macedo A; Trigo D; Abreu M; Guimarães M; Luís N; Pinho R; Tavares R
    HIV Med; 2021 Mar; 22(3):212-217. PubMed ID: 33012065
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.